银屑病相关流行病学调查进展

doi:10.16150/j.1671-2870.2021.01.007

摘要/Abstract

关键词: 银屑病, 流行病学调查, 患病率, 共病

中图分类号:

R758.63

黄丹, 陈崑. 银屑病相关流行病学调查进展[J]. 诊断学理论与实践, 2021, 20(01): 48-52.

参考文献 33

[1]	Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis[J]. J Eur Acad Dermatol Venereol, 2017, 31(2):205-212. doi: 10.1111/jdv.13854 pmid: 27573025
[2]	Parisi R, Iskandar IYK, Kontopantelis E, et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study[J]. BMJ, 2020, 369:m1590.
[3]	Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris[J]. J Am Acad Dermatol, 1985, 13(3):450-456. pmid: 4056119
[4]	Pezzolo E, Cazzaniga S, Colombo P, et al. Psoriasis incidence and lifetime prevalence: suggestion for a higher mortality rate in older age-classes among psoriatic patients compared to the general population in Italy[J]. Acta Derm Venereol, 2019, 99(4):400-403. doi: 10.2340/00015555-3130 URL
[5]	全国银屑病流行调查组, 邵长庚, 张国威, 等. 全国1984年银屑病流行调查报告[J]. 皮肤病与性病, 1989, 11(1):60-72.
[6]	Ding X, Wang T, Shen Y, et al. Prevalence of psoriasis in China: a population-based study in six cities[J]. Eur J Dermatol, 2012, 22(5):663-667. doi: 10.1684/ejd.2012.1802 URL
[7]	陈映玲. 湖北省银屑病流行病学调查报告[J]. 皮肤病与性病, 1990, 12(4):51-56.
[8]	杜升东. 辽宁省银屑病流行病学调查报告[J]. 皮肤病与性病, 1993, 15(1):72-76.
[9]	李梅娇, 王鹏, 蔡敏, 等. 海南省银屑病患病情况及危险因素流行病学调查[J]. 中华皮肤科杂志, 2013, 46(3):157-159.
[10]	刘承煌, 毛维翰, 李君蒂, 等. 上海市1985年银屑病流行病学调查报告[J]. 皮肤病与性病, 1990, 12(2):56-65.
[11]	裴广德, 杜金锋, 黄英, 等. 河南省焦作地区银屑病流行病学调查[J]. 临床皮肤科杂志, 2011, 40(3):150-151.
[12]	包寅德, 曹元华, 陈素玲, 等. 江苏省泰州市及周围县八个乡的银屑病流行情况的调查报告[J]. 皮肤病与性病, 1990, 12(2):48-55.
[13]	广州市皮肤病防治所. 广州市银屑病流行病学调查总结[J]. 皮肤病与性病, 1993, 15(2):71-77.
[14]	Chen K, Wang G, Jin H, et al. Clinic characteristics of psoriasis in China: a nationwide survey in over 12000 patients[J]. Oncotarget, 2017, 8(28):46381-46389. doi: 10.18632/oncotarget.18453 pmid: 28637026
[15]	张学军, 陈珊宇, 王福喜, 等. 寻常型银屑病遗传流行病学分析[J]. 中华皮肤科杂志, 2000, 33(6):383.
[16]	Kamiya K, Kishimoto M, Sugai J, et al. Risk factors for the development of psoriasis[J]. Int J Mol Sci, 2019, 20(18):4347. doi: 10.3390/ijms20184347 URL
[17]	Jullien D, Paul C, Shourick J, et al. Psoriasis: frequency and reasons for absenteeism results from a study on 1,609 active patients[J/OL]. J Eur Acad Dermatol Vene-reol, 2020-12-02[2021-02-22]. https://pubmed.ncbi.nlm.nih.gov/33289175/.
[18]	Szczerkowska-Dobosz A, Krasowska D, Bartosińska J, et al. Pathogenesis of psoriasis in the "omic" era. Part Ⅳ. Epidemiology, genetics, immunopathogenesis, clinical manifestation and treatment of psoriatic arthritis[J]. Postepy Dermatol Alergol, 2020, 37(5):625-634.
[19]	Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics[J]. J Am Acad Dermatol, 2013, 69(5):729-735. doi: 10.1016/j.jaad.2013.07.023 URL
[20]	Ogdie A, Weiss P. The epidemiology of psoriatic arthritis[J]. Rheum Dis Clin North Am, 2015, 41(4):545-568. doi: 10.1016/j.rdc.2015.07.001 URL
[21]	戴生明, 毕新岭. 银屑病关节炎[M]. 人民卫生出版社, 2017.
[22]	Woo YR, Park CJ, Kang H, et al. The risk of systemic diseases in those with psoriasis and psoriatic arthritis: from mechanisms to clinic[J]. Int J Mol Sci, 2020, 21(19):7041. doi: 10.3390/ijms21197041 URL
[23]	Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology[J]. J Am Acad Dermatol, 2017, 76(3):377-390. doi: S0190-9622(16)30626-0 pmid: 28212759
[24]	Ahlehoff O, Gislason GH, Charlot M, et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study[J]. J Intern Med, 2011, 270(2):147-157. doi: 10.1111/j.1365-2796.2010.02310.x pmid: 21114692
[25]	Gui XY, Yu XL, Jin HZ, et al. Prevalence of metabolic syndrome in Chinese psoriasis patients: a hospital-based cross-sectional study[J]. J Diabetes Investig, 2018, 9(1):39-43. doi: 10.1111/jdi.12663 URL
[26]	Vaengebjerg S, Skov L, Egeberg A, et al. Prevalence, incidence, and risk of cancer in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis[J]. JAMA Dermatol, 2020, 156(4):421-429. doi: 10.1001/jamadermatol.2020.0024 pmid: 32074260
[27]	Wu JJ, Nguyen TU, Poon KY, et al. The association of psoriasis with autoimmune diseases[J]. J Am Acad Dermatol, 2012, 67(5):924-930. doi: 10.1016/j.jaad.2012.04.039 URL
[28]	Tian Z, Huang Y, Yue T, et al. A Chinese cross-sectional study on depression and anxiety symptoms in patients with psoriasis vulgaris[J]. Psychol Health Med, 2019, 24(3):269-280. doi: 10.1080/13548506.2018.1529323 URL
[29]	李蔚然. 基于银屑病全球监测项目的中国银屑病医疗保健现状研究及银屑病与肥胖、Ⅱ型糖尿病的因果关系探讨[D]. 安徽: 安徽医科大学, 2020.
[30]	Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review[J]. JAMA, 2020, 323(19):1945-1960. doi: 10.1001/jama.2020.4006 pmid: 32427307
[31]	Kaushik SB, Lebwohl MG. Psoriasis: Which therapy for which patient: psoriasis comorbidities and preferred systemic agents[J]. J Am Acad Dermatol, 2019, 80(1):27-40. doi: 10.1016/j.jaad.2018.06.057 URL
[32]	Strober B, Gooderham M, de Jong EMGJ, et al. Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry(PSOLAR)[J]. J Am Acad Dermatol, 2018, 78(1):70-80. doi: S0190-9622(17)32316-2 pmid: 29102053
[33]	陈小兰, 郑丽英, 张昊, 等. 银屑病患者疾病负担和生存质量调查:基于网络的问卷调查[J]. 中华皮肤科杂志, 2019, 52(11):791-795.

银屑病相关流行病学调查进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 33

相关文章 15

编辑推荐

Metrics

本文评价

[1]	周新, 张旻. 中国支气管哮喘防治指南（2020年版）解读[J]. 诊断学理论与实践, 2021, 20(02): 138-143.
[2]	史玉玲. 英国《皮肤科医师协会银屑病生物制剂治疗指南》（2020版）解读[J]. 诊断学理论与实践, 2021, 20(01): 37-42.
[3]	林镇, 郭茹茹, 吕良敬, 陈晓翔. Fra2通过调节白细胞介素23受体参与银屑病发病的研究[J]. 诊断学理论与实践, 2018, 17(03): 254-259.
[4]	戴生明. 银屑病关节炎的危害、诊治现状[J]. 诊断学理论与实践, 2018, 17(03): 238-243.
[5]	王芳, 林见敏, 陈辉凤, 王金金, 张建林, 邓燕燕, 龚倩. 上海青浦2015年至2016年2 241例呼吸道感染患者9项常见病原体检出情况分析[J]. 诊断学理论与实践, 2018, 17(02): 207-210.
[6]	李琳, 牛静雅, 王天歌, 李勉, 赵志云, 徐瑜, 陆洁莉, 徐敏, 毕宇芳, 王卫庆, 高金丽. 上海市淞南社区中老年人群冠状动脉粥样硬化患病率CCTA调查结果及相关因素分析[J]. 诊断学理论与实践, 2018, 17(01): 38-44.
[7]	肖显超, 刘玉佳, 王刚, 孙成林, 赫广玉, 王桂侠,. 比较不同肥胖评价指标对脂代谢异常的预测能力[J]. 诊断学理论与实践, 2016, 15(04): 360-363.
[8]	魏方菲, 张璐, 韩静岭, 李燕,. 单纯舒张期高血压的患病率及临床特征[J]. 诊断学理论与实践, 2012, 11(06): 568-571.
[9]	鲁智勇, 郑捷,. 银屑病病情严重程度的评价方法[J]. 诊断学理论与实践, 2009, 8(03): 360-362.
[10]	陈颖炜, 陈小英, 邬玉美, 鲁智勇, 薛峰, 潘萌, 施若非, 郑捷,. 银屑病患者白介素-20基因多态性和临床表型研究[J]. 诊断学理论与实践, 2008, 7(05): 521-525.
[11]	宋珺, 郑捷,. 银屑病与白细胞介素-10关系的研究进展[J]. 诊断学理论与实践, 2007, 6(01): 71-73.
[12]	陈珏, 曹华, 潘萌, 郑捷,. 寻常型银屑病伴大疱性皮肤病的诊断和临床分析[J]. 诊断学理论与实践, 2006, 5(04): 306-307.
[13]	李志艳,徐国宾,夏铁安. 北京市部分职业人员血脂水平及血脂异常流行情况[J]. 诊断学理论与实践, 2004, 3(05): 21-26.
[14]	王振,肖泽萍,张海音,陈珏,邹政. 强迫症的临床特征及其与人格障碍的共病情况分析[J]. 诊断学理论与实践, 2004, 3(02): 46-48+56.
[15]	林果为. 诊断试验的研究与评价[J]. 诊断学理论与实践, 2003, 2(01): 89-92.